SEC Form 4 · accession 0000899243-15-006390
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason B. Shandell
Officer — President · Director
Period of report
Oct 3, 2015
Accepted (ET)
Oct 6, 2015 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 3, 2015 | F | 987 | $11.69 | D | 159,030 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of deferred stock units. or DSUs.